Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Levels of serum apelin (s-apelin), an endogenous ligand for angiotensin-like receptor 1, have been shown to be related to hepatic fibrosis and hemodynamic abnormalities in preclinical studies. We investigated the clinical implications of s-apelin as a noninvasive prognostic biomarker for chronic liver disease (CLD). Methods: From January 2009 to December 2012, 215 CLD patients were enrolled and underwent clinical data collection, hepatic venous pressure gradient (HVPG) measurement, and liver biopsy. s-apelin was detected with a human total apelin enzyme-linked immunosorbent assay kit. All patients were prospectively observed during the median follow-up period of 23.0±12.9 months for decompensation and mortality. Results: A total of 42 patients (19.5%) died during the follow-up period. s-apelin was significantly correlated with measurements of liver stiffness (R2=0.263, p<0.001) and collagen proportional area (R2=0.213, p<0.001) measured from liver biopsy tissue and HVPG (R2=0.356, p<0.001). In a multivariate analysis using a Cox regression hazard model, s-apelin was a weakly significant predictor of decompensation (hazard ratio [HR], 1.002; p<0.001) and mortality (HR, 1.003; p<0.001). Conclusions: s-apelin showed a significant relationship with CLD severity. However, its significance as a noninvasive biomarker for disease severity and prognosis was weak.
Abstract
Background/Aims: Levels of serum apelin (s-apelin), an endogenous ligand for angiotensin-like receptor 1, have been shown to be related to hepatic fibrosis and hemodynamic abnormalities in preclinical studies. We investigated the clinical implications of s-apelin as a noninvasive prognostic biomarker for chronic liver disease (CLD). Methods: From January 2009 to December 2012, 215 CLD patients were enrolled and underwent clinical data collection, hepatic venous pressure gradient (HVPG) measurement, and liver biopsy. s-apelin was detected with a human total apelin enzyme-linked immunosorbent assay kit. All patients were prospectively observed during the median follow-up period of 23.0±12.9 months for decompensation and mortality. Results: A total of 42 patients (19.5%) died during the follow-up period. s-apelin was significantly correlated with measurements of liver stiffness (R2=0.263, p<0.001) and collagen proportional area (R2=0.213, p<0.001) measured from liver biopsy tissue and HVPG (R2=0.356, p<0.001). In a multivariate analysis using a Cox regression hazard model, s-apelin was a weakly significant predictor of decompensation (hazard ratio [HR], 1.002; p<0.001) and mortality (HR, 1.003; p<0.001). Conclusions: s-apelin showed a significant relationship with CLD severity. However, its significance as a noninvasive biomarker for disease severity and prognosis was weak.
참고문헌 (21)
- Arvaniti V, "Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis", Gastroenterology, 139, pp.1246~1256 (2010)
- Garcia-Tsao G, "Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis", Hepatology, 51, pp.1445~1449 (2010)
- Kim MY, "Hemodynamic alterations in cirrhosis and portal hypertension", Korean J Hepatol, 16, pp.347~352 (2010)
- 박의주, "The Risk Factors for Bleeding of Fundal Varices in Patients with Liver Cirrhosis", Gut and Liver, 7(6), pp.704~711 (2013), 거트앤리버 발행위원회
- 이태훈, "Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score", Gut and Liver, 7(3), pp.323~328 (2013), 거트앤리버 발행위원회
- Garcia-Tsao G, "Outpatient liver biopsy: how safe is it?", Ann Intern Med, 118, pp.150~153 (1993)
- Lebrec D, "Methods to evaluate portal hypertension", Gastroenterol Clin North Am, 21, pp.41~59 (1992)
- Kim MY, "Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis", Hepatology, 56, pp.1053~1062 (2012)
- O’Dowd BF, "A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11", Gene, 136, pp.355~360 (1993)
- Tatemoto K, "Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor", Biochem Biophys Res Commun, 251, pp.471~476 (1998)
- Ishida J, "Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo", J Biol Chem, 279, pp.26274~26279 (2004)
- Tatemoto K, "The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism", Regul Pept, 99, pp.87~92 (2001)
- De Mota N, "Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release", Proc Natl Acad Sci U S A, 101, pp.10464~10469 (2004)
- Principe A, "The hepatic apelin system: a new therapeutic target for liver disease", Hepatology, 48, pp.1193~1201 (2008)
- Tiani C, "Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension", J Hepatol, 50, pp.296~305 (2009)
- Melgar-Lesmes P, "Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes", Gut, 60, pp.1404~1411 (2011)
- Kim MY, "Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis", Eur J Gastroenterol Hepatol, 21, pp.1241~1246 (2009)
- de Franchis R, "Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension", J Hepatol, 33, pp.846~852 (2000)
- 홍원기, "The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data", Clinical and Molecular Hepatology, 19(4), pp.370~375 (2013), 대한간학회
- Kim MY, "Invasive and non-invasive diagnosis of cirrhosis and portal hypertension", World J Gastroenterol, 20, pp.4300~4315 (2014)
- Tsochatzis E, "Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis", J Hepatol, 60, pp.948~954 (2014)